Nome | Settore | Analyst Name | Analyst Job Title | Rating Quantitativo | Data | |
---|---|---|---|---|---|---|
Gilead Sciences Inc | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
GSK PLC | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
GSK PLC ADR | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Johnson & Johnson | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Merck & Co Inc | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Moderna Inc | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Novartis AG ADR | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Novartis AG Registered Shares | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Novo Nordisk AS ADR | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Novo Nordisk AS Class B | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Pfizer Inc | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Regeneron Pharmaceuticals Inc | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Roche Holding AG | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Roche Holding AG ADR | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Sanofi SA | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Sanofi SA ADR | Salute | Karen Andersen | Strategist | 18/11/2024 | ||
Stifel Financial Corp | Finanza | Michael Wong | Director | 18/11/2024 | ||
Morgan Stanley | Finanza | Michael Wong | Director | 18/11/2024 | ||
Clinuvel Pharmaceuticals Ltd | Salute | Shane Ponraj | Equity Analyst | 18/11/2024 | ||
Regis Healthcare Ltd | Salute | Shane Ponraj | Equity Analyst | 18/11/2024 |